Insured and Non-Insured Glaucoma Treatment Cases in Accordance with the Russian Compulsory Health Insurance System
https://doi.org/10.47619/2713-2617.zm.2026.v.7i2;196-202
Abstract
The article discusses insurance and non-insurance cases of glaucoma treatment within the Russian Compulsory Health Insurance (CHI) system, addressing glaucoma as an eye disease that generally refers to a group of conditions covered within the basic CHI program, including primary health care and specialized medical care in accordance with the Program of State Guarantees of Free Medical Care, procedures, standards, and clinical recommendations. The study demonstrates that the differentiation between insured and non-insured glaucoma cases depends not only on the diagnosis but also on the legal status of the patient, care setting, indications and validation of a treatment against the Program of State Guarantees. In conclusion, in order to confirm the eligibility of a glaucoma treatment, it is necessary to take into account the connection between the Federal Law on Compulsory Health Insurance, the Program of State Guarantees of Free Medical Care, legislation on public health protection, and current glaucoma clinical guidelines.
About the Author
P. L. Luginin
Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department
Russian Federation
Russian Federation
Pavel L. Luginin – Postgraduate Student at the Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department.
9, Sharikopodshipnikovskaya ul., 115088, Moscow
References
1. Konovalova O.S., Shiripova U.A., Andryukhina A.S. et al. Study of the Results of Medical Examination of Rural Patients with Glaucoma. Proceedings of the XXII Scientific and Practical Conference of Ophthalmologists on Surgical and Conservative Treatment of Diseases of the Visual Organ. Yekaterinburg. 2014:41-43. (In Russ.)
2. Diagnosis and Treatment of Primary Open-Angle Glaucoma. Interregional Public Organization “Association of Ophthalmologists”. Federal Clinical Guidelines. Helmholtz National Medical Research Center of Eye Diseases. Moscow. 2012:3. (In Russ.)
3. Datskikh E.O., Rudneva L.F., Konovalova O.S. et al. Tactics of Glaucoma Treatment as Systematic Pathology at Patients of Advanced and Old Age at the Background of Bodily Disease. Medical Science and Education of Ural. 2015;16;1(81):7-10. (In Russ.)
4. Alekseev V.N., Gazizova I.R. Neurodegenerative Changes in Patients with Primary Open-Angle Glaucoma. Practical medicine. 2012;4:154-156. (In Russ.)
5. Gazizova I.R. Glaucoma as a Neurodegenerative Disease. Russian Medical Journal. Clinical ophthalmology. 2014;14;3:123-127. (In Russ.)
Review
For citations:
Luginin P.L. Insured and Non-Insured Glaucoma Treatment Cases in Accordance with the Russian Compulsory Health Insurance System. City Healthcare. 2026;7(2):196-202. (In Russ.) https://doi.org/10.47619/2713-2617.zm.2026.v.7i2;196-202
Views:
10
JATS XML
Email this article 